Internal Medicine · Lubbock, TX
NPI
1053322016
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
808 Joliet Ave Unit 220
Lubbock, TX, 79415
Phone (806) 761-0566
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
3,626 services
Medicare patients, 2024
544
Average age 74
Drug cost, 2024
$2.8M
26,593 prescriptions
Company payments, 2025
$2,599
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael G McPherson was code 99214 (office e&m - established), 453 times for 261 patients. In total Michael G McPherson billed 3,626 services in 81 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 453 | 261 | $81.55 | $37K |
| 85025 Blood Count | Office | 379 | 251 | $7.59 | $2,878 |
| 80053 Clinical Chemistry | Office | 378 | 255 | $10.31 | $3,896 |
| 84443 Clinical Chemistry | Office | 246 | 207 | $16.46 | $4,049 |
| 83036 Blood Count | Office | 216 | 88 | $9.45 | $2,041 |
| 80061 Clinical Chemistry | Office | 206 | 187 | $13.01 | $2,679 |
| 99232 Hospital E&M - Subsequent | Facility | 201 | 174 | $63.52 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 188 | 188 | $133.72 | $25K |
| 99213 Office E&M - Established | Office | 131 | 110 | $62.04 | $8,128 |
| 99223 Hospital E&M - Initial | Facility | 121 | 109 | $134.49 | $16K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 121 | 121 | $19.35 | $2,342 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 97 | 23 | $0.62 | $60.31 |
| 36415 Venipuncture Blood Collection | Office | 92 | 78 | $8.56 | $788 |
| 96372 Injection Administration | Office | 61 | 44 | $9.63 | $587 |
| 84439 Clinical Chemistry | Office | 56 | 41 | $8.84 | $495 |
By year: 2022 $143K for 3,716 services; 2023 $130K for 3,273 services; 2024 $137K for 3,626 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 379 | 251 | $7.59 | $2,878 |
| 80053 Clinical Chemistry | 378 | 255 | $10.31 | $3,896 |
| 84443 Clinical Chemistry | 246 | 207 | $16.46 | $4,049 |
| 83036 Blood Count | 216 | 88 | $9.45 | $2,041 |
| 80061 Clinical Chemistry | 206 | 187 | $13.01 | $2,679 |
| 36415 Venipuncture Blood Collection | 92 | 78 | $8.56 | $788 |
| 84439 Clinical Chemistry | 56 | 41 | $8.84 | $495 |
| 84403 Clinical Chemistry | 25 | 19 | $25.29 | $632 |
| 80048 Clinical Chemistry | 21 | 19 | $8.29 | $174 |
| 84550 Clinical Chemistry | 17 | 16 | $4.43 | $75.31 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael G McPherson prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,269 prescriptions and refills. In total Michael G McPherson wrote 26,593 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,269 | 2,394 | 294 | $14K |
| Atorvastatin Calcium Generic | 1,056 | 2,002 | 301 | $11K |
| Amlodipine Besylate Generic | 887 | 1,633 | 226 | $6,632 |
| Gabapentin Generic | 751 | 1,126 | 217 | $14K |
| Lisinopril Generic | 737 | 1,435 | 190 | $6,665 |
| Pantoprazole Sodium Generic | 663 | 1,212 | 203 | $9,889 |
| Furosemide Generic | 652 | 893 | 146 | $4,111 |
| Eliquis Apixaban | 541 | 678 | 100 | $278K |
| Potassium Chloride Generic | 525 | 758 | 152 | $12K |
| Losartan Potassium Generic | 524 | 1,197 | 146 | $5,530 |
| Tamsulosin Hcl Generic | 492 | 813 | 123 | $7,854 |
| Metformin Hcl Generic | 434 | 861 | 125 | $4,246 |
| Rosuvastatin Calcium Generic | 419 | 1,000 | 123 | $5,752 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 406 | 406 | 86 | $13K |
| Metoprolol Tartrate Generic | 355 | 522 | 94 | $3,026 |
Brand drugs: 4,728 claims; generic drugs: 21,747 claims; opioid claims: 772.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael G McPherson $2,599 ($2,599 in general payments such as food, travel and fees) from 30 companies. The largest payer was Abbvie Inc. with $338.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $338 |
| Lilly USA, LLC LLY | 18 | $314 |
| GlaxoSmithKline, LLC. GSK | 21 | $242 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $206 |
| Novo Nordisk Inc NVO | 13 | $197 |
| Radius Health, Inc. | 5 | $130 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $115 |
| Lundbeck LLC | 4 | $99.94 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $90.94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $88.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.